南微医学收盘上涨1.84%，滚动市盈率21.49倍，总市值122.63亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Nanwei Medical, which closed at 65.28 yuan with a PE ratio of 21.49 and a total market capitalization of 12.263 billion yuan [1][2] - The average PE ratio for the medical device industry is 49.12, with a median of 36.07, positioning Nanwei Medical at the 49th rank within the industry [1][2] - As of March 31, 2025, the number of shareholders for Nanwei Medical increased to 13,313, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Nanwei Medical specializes in the research, manufacturing, and sales of minimally invasive medical devices, with key products including biopsy, hemostasis, closure devices, EMR/ESD devices, dilation devices, ERCP devices, EUS/EBUS devices, ablation instruments, disposable imaging systems, and related consumables [1] - In the latest quarterly report for Q1 2025, the company reported a revenue of 699 million yuan, reflecting a year-on-year growth of 12.75%, and a net profit of 161 million yuan, also showing a year-on-year increase of 12.18%, with a gross margin of 65.69% [1]